← Home / Jaguar Health, Inc. (JAGX)
Stock Analysis

Jaguar Health, Inc. (JAGX)

JAGX
JAGX · Healthcare • Biotechnology
0.92 -2.46%
Track JAGX in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when JAGX price is:
52W Range Position
0%
LOWMIDHIGH
Trend
Vulnerable
Momentum
Neutral
Updated: 2026-08-26 21:19 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and structural levels before acting.
⚖️
✓
Fundamentals
Weak / Negative / Pressured / Stretched
✓
Price Structure
Vulnerable
•
Momentum
Neutral
×
Current Resistance
Below Resistance
Risk Level
Elevated
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
0.91
↗
Break Above
No reliable confirmation level is currently available.
Not available
🎯
Next Objective
No defined objective is currently available for the primary technical setup.
Not available
×
Thesis Break
No setup-specific invalidation level is currently defined.
Not available
Recent Company Events
SEC VERIFIED
Latest material filings
AUG
19
●
Financial Results
HIGH
JAGX reports financial results
On August 19, 2026, Jaguar Health, Inc.
8-K Filing • SEC EDGAR
JUL
14
●
Management / Board
HIGH
JAGX board and management update
As previously disclosed, on September 3, 2020, Napo Pharmaceuticals, Inc.
8-K Filing • SEC EDGAR
JUL
14
◈
Strategic Agreement
HIGH
JAGX strategic agreement
As previously disclosed, on September 3, 2020, Napo Pharmaceuticals, Inc.
8-K Filing • SEC EDGAR
What's Driving JAGX?
• No active technical setup
Momentum is Neutral. No qualified technical setup is currently active.
⚠ Business quality is weak
Revenue growth is weak. Profitability is negative. Cash generation is pressured. Balance-sheet quality is stretched.
⚠️ Key risk remains
losing 0.91 would weaken the current structure.
Full Analysis Workspace
Technical Signal
No Active Technical Setup
•
No qualified technical setup is currently active.
RSI(14)
37.1
Price Chart
JAGX — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-08-25
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$4.5M
Company size
EV
$17.5M
Debt-adjusted value
P/S
0.2
Low sales multiple
P/B
3.3
Balanced
EV/Sales
0.6
Low sales multiple
EV/EBIT
-0.1
Not meaningful
P/FCF
-2.1
Not meaningful
FCF Yield
-47.23%
Cash return
Not financial advice
Business Lens
Financial pressure is elevated
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Weak
●
Profitability
Negative
≈
Cash Flow
Pressured
⚖
Balance Sheet
Stretched
💵 Revenue
1.23M
↘ Weak
📈 Net Income
-12.80M
↘ Negative
🧮 EPS (Basic)
-15.70
↘ Negative
Jaguar Health, Inc.
Healthcare • Biotechnology
You Might Also Like